Cystoid macular oedema drug begins testing

In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.

Adequate assessment and estimation of residual visual function are important clinically.

Session moderators, speakers and audience members all will examine and analyse the most relevant and controversial issues within the field of ophthalmology.

EMBL-EBI researchers use UK Biobank data to uncover new information about rare diseases of the eye.

A look at what’s in the therapeutic delivery pipeline for these disorders.

The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.